PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
68.88%
Positive growth while CRK shows revenue decline. John Neff would investigate competitive advantages.
10.94%
Cost increase while CRK reduces costs. John Neff would investigate competitive disadvantage.
144.69%
Positive growth while CRK shows decline. John Neff would investigate competitive advantages.
44.89%
Margin expansion while CRK shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
2038.10%
G&A growth above 1.5x CRK's 34.47%. Michael Burry would check for operational inefficiency.
No Data
No Data available this quarter, please select a different quarter.
1300.00%
Other expenses growth above 1.5x CRK's 10.99%. Michael Burry would check for concerning trends.
159.58%
Operating expenses growth above 1.5x CRK's 34.89%. Michael Burry would check for inefficiency.
42.59%
Total costs growth while CRK reduces costs. John Neff would investigate differences.
-1.03%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-4.81%
Both companies reducing D&A. Martin Whitman would check industry patterns.
101.86%
EBITDA growth while CRK declines. John Neff would investigate advantages.
-17.51%
Both companies show margin pressure. Martin Whitman would check industry conditions.
2810.71%
Operating income growth while CRK declines. John Neff would investigate advantages.
1705.10%
Operating margin growth while CRK declines. John Neff would investigate advantages.
-395.00%
Other expenses reduction while CRK shows 127.70% growth. Joel Greenblatt would examine advantage.
925.00%
Pre-tax income growth while CRK declines. John Neff would investigate advantages.
588.51%
Pre-tax margin growth exceeding 1.5x CRK's 0.99%. David Dodd would verify competitive advantages.
325.81%
Tax expense growth while CRK reduces burden. John Neff would investigate differences.
7116.67%
Net income growth while CRK declines. John Neff would investigate advantages.
4254.78%
Net margin growth while CRK declines. John Neff would investigate advantages.
7112.99%
EPS growth while CRK declines. John Neff would investigate advantages.
7236.56%
Diluted EPS growth while CRK declines. John Neff would investigate advantages.
0.04%
Share count reduction exceeding 1.5x CRK's 0.87%. David Dodd would verify capital allocation.
-1.80%
Diluted share reduction while CRK shows 0.38% change. Joel Greenblatt would examine strategy.